Smithwood Advisers Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$77.8M |
| 2 |
YPF Sociedad Anonima ADS
YPF
|
+$76.5M |
| 3 |
Microsoft
MSFT
|
+$60.7M |
| 4 |
AstraZeneca
AZN
|
+$47M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$32.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$84.1M |
| 2 |
NetApp
NTAP
|
+$44.3M |
| 3 |
KATE
Kate Spade & Company
KATE
|
+$39.4M |
| 4 |
PPLI
People Inc
PPLI
|
+$35.7M |
| 5 |
Vodafone
VOD
|
+$35.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 24.26% |
| 2 | Technology | 12.85% |
| 3 | Communication Services | 12.68% |
| 4 | Healthcare | 11.86% |
| 5 | Industrials | 10.71% |
Similar funds
Smithwood Advisers's Q2 2014 Portfolio in Review
As of Q2 2014, Smithwood Advisers held 49 positions worth $1.4B, down 1.7% from $1.43B the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Smithwood Advisers withdrew a net $48.9M in Q2 2014, closing 14 positions and reducing 12 holdings. Its most notable exit was DIRECTV COM STK (DE), an estimated $84.1M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 24% of assets, down from 28% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Smithwood Advisers opened a new position in Allergan Inc worth $84.6M.
- Smithwood Advisers's largest Q2 2014 buy was Allergan Inc: 500,000 shares worth $84.6M.
- Smithwood Advisers added most to YPF Sociedad Anonima ADS in Q2 2014, an estimated $76.5M increase.
- Smithwood Advisers's biggest Q2 2014 reduction was Kate Spade & Company, cutting an estimated $39.4M.
- Smithwood Advisers fully exited DIRECTV COM STK (DE) in Q2 2014, selling an estimated $84.1M.
- Smithwood Advisers's ten largest holdings make up 51% of its $1.4B portfolio in Q2 2014.
- Smithwood Advisers opened 9 new positions and closed 14 in Q2 2014.
- Smithwood Advisers's portfolio value fell 1.7% quarter-over-quarter to $1.4B.
Based on Smithwood Advisers's 13F filing for Q2 2014, filed 14 Aug 2014.